1. Home
  2. ZNTL vs PANL Comparison

ZNTL vs PANL Comparison

Compare ZNTL & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • PANL
  • Stock Information
  • Founded
  • ZNTL 2014
  • PANL 1996
  • Country
  • ZNTL United States
  • PANL United States
  • Employees
  • ZNTL N/A
  • PANL N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • ZNTL Health Care
  • PANL Consumer Discretionary
  • Exchange
  • ZNTL Nasdaq
  • PANL Nasdaq
  • Market Cap
  • ZNTL 227.0M
  • PANL 257.0M
  • IPO Year
  • ZNTL 2020
  • PANL N/A
  • Fundamental
  • Price
  • ZNTL $3.00
  • PANL $4.92
  • Analyst Decision
  • ZNTL Buy
  • PANL Strong Buy
  • Analyst Count
  • ZNTL 8
  • PANL 1
  • Target Price
  • ZNTL $10.50
  • PANL N/A
  • AVG Volume (30 Days)
  • ZNTL 1.1M
  • PANL 233.2K
  • Earning Date
  • ZNTL 11-12-2024
  • PANL 11-12-2024
  • Dividend Yield
  • ZNTL N/A
  • PANL 8.26%
  • EPS Growth
  • ZNTL N/A
  • PANL N/A
  • EPS
  • ZNTL N/A
  • PANL 0.47
  • Revenue
  • ZNTL $40,560,000.00
  • PANL $521,238,386.00
  • Revenue This Year
  • ZNTL N/A
  • PANL $8.04
  • Revenue Next Year
  • ZNTL N/A
  • PANL $13.05
  • P/E Ratio
  • ZNTL N/A
  • PANL $10.24
  • Revenue Growth
  • ZNTL N/A
  • PANL 5.23
  • 52 Week Low
  • ZNTL $2.66
  • PANL $4.84
  • 52 Week High
  • ZNTL $18.07
  • PANL $9.53
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 41.60
  • PANL 26.60
  • Support Level
  • ZNTL $2.80
  • PANL $4.93
  • Resistance Level
  • ZNTL $4.00
  • PANL $5.29
  • Average True Range (ATR)
  • ZNTL 0.27
  • PANL 0.18
  • MACD
  • ZNTL -0.06
  • PANL -0.03
  • Stochastic Oscillator
  • ZNTL 17.01
  • PANL 7.53

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.

Share on Social Networks: